Food businesses would see clearer rules and lower fees for small businesses during FDA inspections.
This bill would update how the Food and Drug Administration (FDA) charges fees for reinspections and recalls of food products. It would set clear fee amounts, offer discounts for small businesses, and define what counts as a reinspection or a small business. This aims to fix current technical issues in the FDA's fee collection process.
Today, the FDA collects fees for reinspections and recalls, but the rules for these fees have technical issues regarding calculation, amounts, and definitions. If this bill becomes law, the FDA would have clearer rules. It would set specific fees, such as $15,000 for many reinspections starting in the government's budget year 2026. It would also offer a one-third fee reduction for qualifying small businesses. The total amount the FDA could collect annually would also increase, with one cap rising from $20 million to $25 million, and another from $25 million to $30 million.
S 3252 · 119th Congress · November 20, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers